• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Whither vaccines?疫苗何去何从?
J Infect. 2017 Jun;74 Suppl 1:S2-S9. doi: 10.1016/S0163-4453(17)30184-6.
2
Vaccines for epidemic infections and the role of CEPI.针对传染病的疫苗和 CEPI 的作用。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2755-2762. doi: 10.1080/21645515.2017.1306615. Epub 2017 Apr 4.
3
Opportunities for vaccine research in Europe.欧洲疫苗研究的机遇。
Hum Vaccin Immunother. 2015;11(8):1917-20. doi: 10.1080/21645515.2015.1016680.
4
Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.传染病研究投资:英国免疫学和疫苗研究资金的系统分析。
Vaccine. 2013 Dec 5;31(50):5930-3. doi: 10.1016/j.vaccine.2013.10.048. Epub 2013 Oct 25.
5
New vaccines: challenges of discovery.新型疫苗:发现过程中的挑战
Microb Biotechnol. 2016 Sep;9(5):549-52. doi: 10.1111/1751-7915.12397. Epub 2016 Aug 18.
6
A Focus on Vaccine Development.专注于疫苗研发。
Viral Immunol. 2015 Jul-Aug;28(6):303. doi: 10.1089/vim.2015.28999.dlw.
7
The current challenges for vaccine development.当前疫苗研发面临的挑战。
J Med Microbiol. 2012 Jul;61(Pt 7):889-894. doi: 10.1099/jmm.0.039180-0. Epub 2012 Feb 9.
8
Economics and financing of vaccines for diarrheal diseases.腹泻病疫苗的经济学与融资
Hum Vaccin Immunother. 2014;10(6):1568-81. doi: 10.4161/hv.28885. Epub 2014 Apr 22.
9
Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.现代疫苗/佐剂配方——第二场会议(全体会议二):2013年5月15日至17日——瑞士洛桑
Hum Vaccin Immunother. 2013 Sep;9(9):2015-6. doi: 10.4161/hv.26208. Epub 2013 Aug 20.
10
Letter from the editor.编辑来信。
Hum Vaccin Immunother. 2013 Apr;9(4):721. doi: 10.4161/hv.24622.

引用本文的文献

1
Multiomics as instrument to promote 3P medical approaches for the overall management of respiratory syncytial viral infections.多组学作为促进针对呼吸道合胞病毒感染全面管理的3P医学方法的工具。
EPMA J. 2025 Jan 16;16(1):217-238. doi: 10.1007/s13167-024-00395-z. eCollection 2025 Mar.
2
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza.广谱流感mRNA疫苗的优势及其对肺部流感的影响。
Vaccines (Basel). 2024 Dec 7;12(12):1382. doi: 10.3390/vaccines12121382.
3
Applications of microfluidics in mRNA vaccine development: A review.微流控技术在mRNA疫苗研发中的应用:综述
Biomicrofluidics. 2024 Nov 14;18(6):061502. doi: 10.1063/5.0228447. eCollection 2024 Dec.
4
mRNA vaccine design for Epstein-Barr virus: an immunoinformatic approach.爱泼斯坦-巴尔病毒的mRNA疫苗设计:一种免疫信息学方法。
In Silico Pharmacol. 2024 Jul 24;12(2):68. doi: 10.1007/s40203-024-00244-x. eCollection 2024.
5
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks.临床 RNA 治疗学的进展:现状与展望。
Cell Rep Med. 2024 May 21;5(5):101555. doi: 10.1016/j.xcrm.2024.101555. Epub 2024 May 13.
6
Summary of the Current Status of DNA Vaccination for Alzheimer Disease.阿尔茨海默病DNA疫苗接种现状总结
Vaccines (Basel). 2023 Nov 10;11(11):1706. doi: 10.3390/vaccines11111706.
7
Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment.mRNA疫苗在传染病和癌症治疗中的临床分析与应用
Cureus. 2023 Oct 2;15(10):e46354. doi: 10.7759/cureus.46354. eCollection 2023 Oct.
8
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization.用新型宿主衍生免疫刺激剂CPDI-02对可生物降解微粒进行表面修饰,显著提高了幼龄未免疫小鼠经呼吸道免疫后针对包封蛋白抗原的短期和长期黏膜及全身抗体水平。
Pharmaceutics. 2022 Sep 1;14(9):1843. doi: 10.3390/pharmaceutics14091843.
9
mRNA Vaccines as an Efficient Approach for the Rapid and Robust Induction of Host Immunity Against SARS-CoV-2.mRNA疫苗作为快速有效诱导宿主针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)产生免疫的一种方法。
SN Compr Clin Med. 2022;4(1):88. doi: 10.1007/s42399-022-01168-3. Epub 2022 Apr 1.
10
Influenza Viruses: Innate Immunity and mRNA Vaccines.流感病毒:先天免疫与 mRNA 疫苗
Front Immunol. 2021 Aug 31;12:710647. doi: 10.3389/fimmu.2021.710647. eCollection 2021.

本文引用的文献

1
Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection.用于预防和治疗呼吸道合胞病毒感染的新型抗体的研发及临床应用
Vaccine. 2017 Jan 11;35(3):496-502. doi: 10.1016/j.vaccine.2016.09.026. Epub 2016 Sep 28.
2
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.接种疫苗、自然感染和实验性激发所引发的人类流感病毒特异性抗体依赖性细胞毒性的产生及保护能力
J Infect Dis. 2016 Sep 15;214(6):945-52. doi: 10.1093/infdis/jiw262. Epub 2016 Jun 28.
3
Recent innovations in mRNA vaccines.mRNA 疫苗的最新创新。
Curr Opin Immunol. 2016 Aug;41:18-22. doi: 10.1016/j.coi.2016.05.008. Epub 2016 May 26.
4
Harnessing the beneficial heterologous effects of vaccination.利用疫苗接种的有益异源效应。
Nat Rev Immunol. 2016 Jun;16(6):392-400. doi: 10.1038/nri.2016.43. Epub 2016 May 9.
5
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design.逆向疫苗学2.0:人类免疫学指导疫苗抗原设计。
J Exp Med. 2016 Apr 4;213(4):469-81. doi: 10.1084/jem.20151960. Epub 2016 Mar 28.
6
Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.免疫显性登革病毒特异性CD8 + T细胞反应与记忆性PD-1 +表型相关。
J Virol. 2016 Apr 14;90(9):4771-4779. doi: 10.1128/JVI.02892-15. Print 2016 May.
7
Protective role of Th17 cells in pulmonary infection.辅助性T细胞17在肺部感染中的保护作用。
Vaccine. 2016 Mar 18;34(13):1504-1514. doi: 10.1016/j.vaccine.2016.02.021. Epub 2016 Feb 13.
8
Expanding role of cytomegalovirus as a human pathogen.巨细胞病毒作为人类病原体作用的扩展。
J Med Virol. 2016 Jul;88(7):1103-12. doi: 10.1002/jmv.24450. Epub 2016 Jan 5.
9
Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.经鼻引入Fc融合白细胞介素-7可提供针对致命性流感病毒感染的长效预防。
J Virol. 2015 Dec 9;90(5):2273-84. doi: 10.1128/JVI.02768-15.
10
RSV vaccine use--the missing data.呼吸道合胞病毒疫苗的使用——缺失的数据。
Expert Rev Vaccines. 2016;15(2):149-52. doi: 10.1586/14760584.2016.1114419. Epub 2015 Dec 4.

疫苗何去何从?

Whither vaccines?

作者信息

Rodrigues Charlene M C, Pinto Marta V, Sadarangani Manish, Plotkin Stanley A

机构信息

Department of Zoology, University of Oxford, Oxford, UK.

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

出版信息

J Infect. 2017 Jun;74 Suppl 1:S2-S9. doi: 10.1016/S0163-4453(17)30184-6.

DOI:10.1016/S0163-4453(17)30184-6
PMID:28646957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7172359/
Abstract

Currently used vaccines have had major effects on eliminating common infections, largely by duplicating the immune responses induced by natural infections. Now vaccinology faces more complex problems, such as waning antibody, immunosenescence, evasion of immunity by the pathogen, deviation of immunity by the microbiome, induction of inhibitory responses, and complexity of the antigens required for protection. Fortunately, vaccine development is now incorporating knowledge from immunology, structural biology, systems biology and synthetic chemistry to meet these challenges. In addition, international organisations are developing new funding and licensing pathways for vaccines aimed at pathogens with epidemic potential that emerge from tropical areas.

摘要

目前使用的疫苗在消除常见感染方面发挥了重大作用,主要是通过复制自然感染诱导的免疫反应。如今,疫苗学面临着更复杂的问题,如抗体衰减、免疫衰老、病原体免疫逃逸、微生物群导致的免疫偏差、抑制性反应的诱导以及保护性抗原的复杂性。幸运的是,疫苗研发目前正在纳入来自免疫学、结构生物学、系统生物学和合成化学的知识,以应对这些挑战。此外,国际组织正在为针对热带地区出现的具有流行潜力的病原体的疫苗开发新的资金和许可途径。